SEC Filing Analysis: Hims & Hers Health, Inc. (HIMS)

Executive Summary

• Trading Significance: Low
• Key Takeaway: The Chief Legal Officer executed a small, pre-planned sale of stock valued at approximately $112k, representing an insignificant portion of their holdings and the company's market capitalization.
• Market Impact: Neutral. The transaction is too small and was conducted under a Rule 10b5-1 plan, indicating it was not based on immediate, non-public information.

Company Information

Field	Value
Company	Hims & Hers Health, Inc.
Ticker Symbol	HIMS
CIK	0001773751
Industry	SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE

Insider Information

Field	Value
Name	Boughton Soleil
CIK	0001837817
Title/Position	Chief Legal Officer
Relationship	Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-11-10
Transaction Code	S (Sale)
Security Type	Class A Common Stock
Shares Involved	2,637
Price Per Share	$42.53
Total Value	$112,154.61
Shares Owned After	155,856
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$112,154.61
% of Market Cap	0.0012%
Shares Transacted	2,637
% of Shares Outstanding	0.0012%
Post-Transaction Ownership	155,856 shares (0.072% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: For a company with a market capitalization of $9.34 billion, this $112k transaction is financially immaterial.
• Ownership Concentration: The sale represents a very small fraction (approx. 1.66%) of the insider's direct holdings, and their post-transaction ownership remains minimal relative to the total shares outstanding.
• Transaction Significance: The sale is insignificant, falling far below the thresholds for moderate or high significance. Its value is less than 0.1% of market cap and shares transacted are less than 0.1% of shares outstanding.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The transaction's small size and its execution under a pre-scheduled 10b5-1 trading plan remove any implication of the insider acting on new information. No market reaction is expected.

Volume & Sentiment

• Expected Volume Impact: None. The transaction size is negligible compared to daily trading volume.
• Sentiment Indicator: Neutral. This is a routine, automated transaction with no bearing on market sentiment.

Additional Context

Transaction Notes

• Special Circumstances: The filing explicitly states the sale was made pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024. This indicates the sale was pre-arranged and not a spontaneous decision.